Source: www.crainsnewyork.com --- Friday, August 31, 2012
Pfizer Inc. will work with privately held biotechnology company VLST Corp. on a potential immune therapy for Cancer. VLST said Friday it plans to start testing the drug, designated CP-870,893, as a treatment for Cancer in mid-stage clinical trials. The Seattle company has conducted early-stage trials of the drug and said it recently secured $5 million in financing to help fund mid-stage studies. Pfizer and VLST will share the rights to develop and market the drug as a "Cancer vaccine," or a therapy that is designed to stimulate the immune system to fight Cancer. Shares of New York-based Pfizer gained 6 cents to $23.90 in morning trading. ...
Source: http://feeds.crainsnewyork.com/~r/crainsnewyork/latestnews/~3/RkLPrP9qKrI/120839975
Darla Moore newsweek Rihanna Tony Scott UFC 151 empire state building Todd Akin
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.